BA
AGN

Bridgewater Associates’s Allergan Inc AGN Stock Holding History

Bridgewater Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,499
Closed -$2.3M – 404
2014
Q1 		$2.3M Sell
18,499
-22,220
-55% -$2.71M 0.02% 172
2013
Q4 		$4.52M Sell
40,719
-185,322
-82% -$17.7M 0.04% 121
2013
Q3 		$20.4M Sell
226,041
-23,300
-9% -$2.09M 0.17% 9
2013
Q2 		$21M Buy
+249,341
New +$25.9M 0.18% 9

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Bridgewater Associates's AGN Position: Q2 2014 in Review

Bridgewater Associates sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 18,499 shares — an estimated $2.3M sold.

Bridgewater Associates first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $21M in Q2 2013. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Bridgewater Associates reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Bridgewater Associates sold 18,499 Allergan Inc shares in Q2 2014, an estimated $2.3M.
  • Bridgewater Associates first reported a position in Allergan Inc in Q2 2013 and held it in 4 quarters.
  • Bridgewater Associates's Allergan Inc position peaked at $21M in Q2 2013.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Bridgewater Associates's 13F filing for Q2 2014, filed 12 Aug 2014.